PDL BioPharma Announces Developments Related to LENSAR Debt Investment, Will Receive ~$12.5 In Alphaeon Common Stock

By: via Benzinga
PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced recent developments related to its debt investment in LENSAR, Inc. (LENSAR), a ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.